The state of Texas recently served up $81 million to support cancer research, drug discovery and business development, including $20 million - the largest grant - to fund the translation of academic research into biopharmaceutical startup companies.
The Cancer Prevention and Research Institute of Texas (CPRIT) gave the biggest slice of its latest funding pie to the Houston-Area Translational Research Consortium, a partnership between the Institute for Applied Cancer Science at the University of Texas' MD Anderson Cancer Center and Rice University's BioScience Research Collaborative